Factors Influencing the Prognosis of Patients with Intra-Abdominal Infection and Its Value in Assessing Prognosis

References

• ZhangS, HuangW. Epidemiological study of community- and hospital-acquired intraabdominal infections. Chin J Traumatol. 2015;18(2):84–89. doi:10.1016/j.cjtee.2015.07.00326511299
   PubMedGoogle Scholar
• HanG, QiaoX, MaZ. Diagnosis and treatment of intra-abdominal infection complicated with hypothyroidism. Zhonghua Wei Chang Wai Ke Za Zhi. 2018;21(12):1356–1360.30588585
   PubMedGoogle Scholar
• MenichettiF, SgangaG. Definition and classification of intra-abdominal infections. J Chemother. 2009;21(Suppl 1):3–4. doi:10.1179/joc.2009.21.Supplement-1.319622444
   PubMedGoogle Scholar
• SartelliM, CatenaF, AnsaloniL, et al. Complicated intra-abdominal infections worldwide: the definitive data of the CIAOW Study. World J Emerg Surg. 2014;9:37. doi:10.1186/1749-7922-9-3724883079
   PubMed Web of Science ®Google Scholar
• BlotS, AntonelliM, ArvanitiK, et al. Epidemiology of intra-abdominal infection and sepsis in critically ill patients: “AbSeS”, a multinational observational cohort study and ESICM trials group project. Intensive Care Med. 2019;45(12):1703–1717. doi:10.1007/s00134-019-05819-331664501
   PubMed Web of Science ®Google Scholar
• DupontH, FriggeriA, TouzeauJ, et al. Enterococci increase the morbidity and mortality associated with severe intra-abdominal infections in elderly patients hospitalized in the intensive care unit. J Antimicrob Chemother. 2011;66(10):2379–2385. doi:10.1093/jac/dkr30821791444
   PubMed Web of Science ®Google Scholar
• MontraversP, TubachF, LescotT, et al. Short-course antibiotic therapy for critically ill patients treated for postoperative intra-abdominal infection: the DURAPOP randomised clinical trial. Intensive Care Med. 2018;44(3):300–310. doi:10.1007/s00134-018-5088-x29484469
   PubMed Web of Science ®Google Scholar
• RattanR, AllenCJ, SawyerRG, et al. Patients with complicated intra-abdominal infection presenting with sepsis do not require longer duration of antimicrobial therapy. J Am Coll Surg. 2016;222(4):440–446.26920994
   PubMed Web of Science ®Google Scholar
• MazuskiJE, TessierJM, MayAK, et al. The surgical infection society revised guidelines on the management of intra-abdominal infection. Surg Infect (Larchmt). 2017;18(1):1–76. doi:10.1089/sur.2016.26128085573
   PubMed Web of Science ®Google Scholar
• ShreeN, AroraBS, MohilRS, KasanaD, BiswalI. Bacterial profile and patterns of antimicrobial drug resistance in intra-abdominal infections: current experience in a teaching hospital. Indian J Pathol Microbiol. 2013;56(4):388–392. doi:10.4103/0377-4929.12532124441227
   PubMed Web of Science ®Google Scholar
• ZhangS, RenL, LiY, et al. Bacteriology and drug susceptibility analysis of pus from patients with severe intra-abdominal infection induced by abdominal trauma. Exp Ther Med. 2014;7(5):1427–1431. doi:10.3892/etm.2014.160924940451
   PubMed Web of Science ®Google Scholar
• TakesueY, KusachiS, MikamoH, et al. Antimicrobial susceptibility of common pathogens isolated from postoperative intra-abdominal infections in Japan. J Infect Chemother. 2018;24(5):330–340. doi:10.1016/j.jiac.2018.02.01129555391
   PubMed Web of Science ®Google Scholar
• TangH, LuW, YangZ, et al. Risk factors and long-term outcome for postoperative intra-abdominal infection after hepatectomy for hepatocellular carcinoma. Medicine (Baltimore). 2017;96(17):e6795.28445320
   PubMed Web of Science ®Google Scholar
• RungsakulkijN, VassanasiriW, TangtaweeP, et al. Preoperative serum albumin is associated with intra-abdominal infection following major hepatectomy. J Hepatobiliary Pancreat Sci. 2019;26(11):479–489. doi:10.1002/jhbp.67331532926
   PubMed Web of Science ®Google Scholar
• XiaoH, XiaoY, QuanH, LiuW, PanS, OuyangY. Intra-abdominal infection after radical gastrectomy for gastric cancer: incidence, pathogens, risk factors and outcomes. Int J Surg. 2017;48:195–200.28751223
   PubMed Web of Science ®Google Scholar
• JiaL, LuJ, MaX. [Analysis of risk factors of intra-abdominal infection after surgery for colorectal cancer]. Zhonghua Wei Chang Wai Ke Za Zhi. 2016;19(4):409–413. Chinese.27112474
   PubMedGoogle Scholar
• Sánchez-VelázquezP, PeraM, Jiménez-ToscanoM, et al. Postoperative intra-abdominal infection is an independent prognostic factor of disease-free survival and disease-specific survival in patients with stage II colon cancer. Clin Transl Oncol. 2018;20(10):1321–1328. doi:10.1007/s12094-018-1866-829623587
   PubMed Web of Science ®Google Scholar
• TuRH, LinJX, DesiderioJ, et al. Does intra-abdominal infection after curative gastrectomy affect patients’ long-term prognosis? A multi-center study based on a large sample size. Surg Infect (Larchmt). 2019;20(4):271–277. doi:10.1089/sur.2018.24630720387
   PubMed Web of Science ®Google Scholar
• SandersJM, TessierJM, SawyerR, et al. Does isolation of enterococcus affect outcomes in intra-abdominal infections?Surg Infect (Larchmt). 2017;18(8):879–885. doi:10.1089/sur.2017.12128994635
   PubMed Web of Science ®Google Scholar
• WürstleS, HapfelmeierA, WöhrleC, et al. Changes in pathogen spectrum and antimicrobial resistance development in the time-course of acute necrotizing pancreatitis. J Gastroenterol Hepatol. 2019;34(12):2096–2103. doi:10.1111/jgh.1474831157455
   PubMed Web of Science ®Google Scholar
• SartelliM, WeberDG, RuppéE, et al. Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA). World J Emerg Surg. 2016;11:33.27429642
   PubMed Web of Science ®Google Scholar
• BassettiM, EckmannC, GiacobbeDR, SartelliM, MontraversP. Post-operative abdominal infections: epidemiology, operational definitions, and outcomes. Intensive Care Med. 2020;46(2):163–172. doi:10.1007/s00134-019-05841-531701205
   PubMed Web of Science ®Google Scholar
• Pearson-StuttardJ, BlundellS, HarrisT, CookDG, CritchleyJ. Diabetes and infection: assessing the association with glycaemic control in population-based studies. Lancet Diabetes Endocrinol. 2016;4(2):148–158. doi:10.1016/S2213-8587(15)00379-426656292
   PubMed Web of Science ®Google Scholar
• KimEJ, HaKH, KimDJ, ChoiYH. Diabetes and the risk of infection: a national cohort study. Diabetes Metab J. 2019;43(6):804–814. doi:10.4093/dmj.2019.007131701687
   PubMed Web of Science ®Google Scholar
• Abu-AshourW, TwellsLK, ValcourJE, GambleJM. Diabetes and the occurrence of infection in primary care: a matched cohort study. BMC Infect Dis. 2018;18(1):67. doi:10.1186/s12879-018-2975-229402218
   PubMed Web of Science ®Google Scholar
• AndersenSB, Baunbæk EgelundG, JensenAV, PetersenPT, RohdeG, RavnP. Failure of CRP decline within three days of hospitalization is associated with poor prognosis of community-acquired pneumonia. Infect Dis (Lond). 2017;49(4):251–260.27887037
   PubMed Web of Science ®Google Scholar
• SprostonNR, AshworthJJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 2018;9:754. doi:10.3389/fimmu.2018.0075429706967
   PubMed Web of Science ®Google Scholar
• Miguel-BayarriV, Casanoves-LaparraEB, Pallás-BeneytoL, et al. Prognostic value of the biomarkers procalcitonin, interleukin-6 and C-reactive protein in severe sepsis. Med Intensiva. 2012;36(8):556–562. doi:10.1016/j.medin.2012.01.01422495097
   PubMed Web of Science ®Google Scholar
• ReinhartK, BauerM, RiedemannNC, HartogCS. New approaches to sepsis: molecular diagnostics and biomarkers. Clin Microbiol Rev. 2012;25(4):609–634.23034322
   PubMed Web of Science ®Google Scholar
• BartolettiM, AntonelliM, Bruno BlasiFA, et al. Procalcitonin-guided antibiotic therapy: an expert consensus. Clin Chem Lab Med. 2018;56(8):1223–1229. doi:10.1515/cclm-2018-025929874192
   PubMed Web of Science ®Google Scholar
• ZhangJ, QuD, RenXX. Value of procalcitonin in predicting the severity and prognosis of neonates with septicemia. Zhonghua Yi Xue Za Zhi. 2018;98(16):1267–1272.29747317
   PubMedGoogle Scholar
• CabralL, AfreixoV, MeirelesR, et al. Checking procalcitonin suitability for prognosis and antimicrobial therapy monitoring in burn patients. Burns Trauma. 2018;6:10. doi:10.1186/s41038-018-0112-529610766
   PubMed Web of Science ®Google Scholar
• BrancheA, NeeserO, MuellerB, SchuetzP. Procalcitonin to guide antibiotic decision making. Curr Opin Infect Dis. 2019;32(2):130–135. doi:10.1097/QCO.000000000000052230648993
   PubMed Web of Science ®Google Scholar
• BironBM, AyalaA, Lomas-NeiraJL. Biomarkers for sepsis: What is and what might be?Biomark Insights. 2015;10(Suppl 4):7–17.26417200
   PubMedGoogle Scholar
• FarmerD, TessierJM, SandersJM, et al. Age and its impact on outcomes with intra-abdominal infection. Surg Infect (Larchmt). 2017;18(2):77–82. doi:10.1089/sur.2016.18428005468
   PubMed Web of Science ®Google Scholar
• Rojek-JarmulaA, HombachR, KrzychLJ. APACHE II score predicts mortality in patients requiring prolonged ventilation in a weaning center. Anaesthesiol Intensive Ther. 2016;48(4):215–219. doi:10.5603/AIT.a2016.003627595745
   PubMedGoogle Scholar
• LiuX, ShenY, LiZ, et al. Prognostic significance of APACHE II score and plasma suPAR in Chinese patients with sepsis: a prospective observational study. BMC Anesthesiol. 2016;16(1):46. doi:10.1186/s12871-016-0212-327473112
   PubMed Web of Science ®Google Scholar
• GodinjakA, IglicaA, RamaA, et al. Predictive value of SAPS II and APACHE II scoring systems for patient outcome in a medical intensive care unit. Acta Med Acad. 2016;45(2):97–103. doi:10.5644/ama2006-124.16528000485
   PubMedGoogle Scholar
• VincentJL, RussellJA, JacobM, et al. Albumin administration in the acutely ill: what is new and where next?Crit Care. 2014;18(4):231. doi:10.1186/cc1399125042164
   PubMed Web of Science ®Google Scholar
• StrulJ, BrahamDL. Is albumin administration beneficial in patients with sepsis?Br J Hosp Med (Lond). 2016;77(11):666. doi:10.12968/hmed.2016.77.11.66627828746
   PubMed Web of Science ®Google Scholar
• CaironiP, GattinoniL. The clinical use of albumin: the point of view of a specialist in intensive care. Blood Transfus. 2009;7(4):259–267.20011637
   PubMed Web of Science ®Google Scholar
• ArteroA, ZaragozaR, CamarenaJJ, SanchoS, GonzálezR, NogueiraJM. Prognostic factors of mortality in patients with community-acquired bloodstream infection with severe sepsis and septic shock. J Crit Care. 2010;25(2):276–281. doi:10.1016/j.jcrc.2009.12.00420149587
   PubMed Web of Science ®Google Scholar
• RhodesA, EvansLE, AlhazzaniW, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43(3):304–377.28101605
   PubMed Web of Science ®Google Scholar
• DelaneyAP, DanA, McCaffreyJ, FinferS. The role of albumin as a resuscitation fluid for patients with sepsis: a systematic review and meta-analysis. Crit Care Med. 2011;39(2):386–391. doi:10.1097/CCM.0b013e3181ffe21721248514
   PubMed Web of Science ®Google Scholar
• CaironiP, TognoniG, MassonS, et al. Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med. 2014;370(15):1412–1421. doi:10.1056/NEJMoa130572724635772
   PubMed Web of Science ®Google Scholar